BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2824039)

  • 1. Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants.
    Rozhin J; Robinson D; Stevens MA; Lah TT; Honn KV; Ryan RE; Sloane BF
    Cancer Res; 1987 Dec; 47(24 Pt 1):6620-8. PubMed ID: 2824039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors.
    Rozhin J; Gomez AP; Ziegler GH; Nelson KK; Chang YS; Fong D; Onoda JM; Honn KV; Sloane BF
    Cancer Res; 1990 Oct; 50(19):6278-84. PubMed ID: 2400991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential.
    Sloane BF; Honn KV; Sadler JG; Turner WA; Kimpson JJ; Taylor JD
    Cancer Res; 1982 Mar; 42(3):980-6. PubMed ID: 7059993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin B: association with plasma membrane in metastatic tumors.
    Sloane BF; Rozhin J; Johnson K; Taylor H; Crissman JD; Honn KV
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2483-7. PubMed ID: 3458210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin B-like activity in viable tumor cells isolated from rodent tumors.
    Ryan RE; Crissman JD; Honn KV; Sloane BF
    Cancer Res; 1985 Aug; 45(8):3636-41. PubMed ID: 3893687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cell surface cathepsin B-like activity on murine melanomas and fibrosarcomas: modulation by butanol extraction.
    Keren Z; LeGrue SJ
    Cancer Res; 1988 Mar; 48(6):1416-21. PubMed ID: 3345513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intracellular form of cathepsin B contributes to invasiveness in cancer.
    Szpaderska AM; Frankfater A
    Cancer Res; 2001 Apr; 61(8):3493-500. PubMed ID: 11309313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The malignant phenotype and cysteine proteinases.
    Sloane BF; Rozhin J; Krepela E; Ziegler G; Sameni M
    Biomed Biochim Acta; 1991; 50(4-6):549-54. PubMed ID: 1801721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of proteolytic enzymes in an in vivo mouse model for experimental metastasis.
    Ostrowski LE; Ahsan A; Suthar BP; Pagast P; Bain DL; Wong C; Patel A; Schultz RM
    Cancer Res; 1986 Aug; 46(8):4121-8. PubMed ID: 3089587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissues.
    Qian F; Bajkowski AS; Steiner DF; Chan SJ; Frankfater A
    Cancer Res; 1989 Sep; 49(17):4870-5. PubMed ID: 2758418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of cathepsin B and other lysosomal proteinases in normal tissues and in tumors.
    Qian F; Chan SJ; Gong QM; Bajkowski AS; Steiner DF; Frankfater A
    Biomed Biochim Acta; 1991; 50(4-6):531-40. PubMed ID: 1801719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of beta-hexosaminidase secretion in rabbit lacrimal gland.
    Andersson SV; Edman MC; Bekmezian A; Holmberg J; Mircheff AK; Gierow JP
    Exp Eye Res; 2006 Nov; 83(5):1081-8. PubMed ID: 16839547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin B and cystatins: evidence for a role in cancer progression.
    Sloane BF
    Semin Cancer Biol; 1990 Apr; 1(2):137-52. PubMed ID: 2103490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane lipids and enzymes of cultured high- and low-metastatic B16 melanoma variants.
    Schroeder F; Gardiner JM
    Cancer Res; 1984 Aug; 44(8):3262-9. PubMed ID: 6146400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of intact lysosomes from human RPE cells and effects of A2-E on the integrity of the lysosomal and other cellular membranes.
    Schütt F; Bergmann M; Holz FG; Kopitz J
    Graefes Arch Clin Exp Ophthalmol; 2002 Dec; 240(12):983-8. PubMed ID: 12483320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of melanoma plasma membrane proteinases: inhibition of collagenolytic and cytolytic activities by minocycline.
    Zucker S; Lysik RM; Ramamurthy NS; Golub LM; Wieman JM; Wilkie DP
    J Natl Cancer Inst; 1985 Sep; 75(3):517-25. PubMed ID: 2993728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of proteolytic enzymes in the in vitro amnion model for basement membrane invasion.
    Persky B; Ostrowski LE; Pagast P; Ahsan A; Schultz RM
    Cancer Res; 1986 Aug; 46(8):4129-34. PubMed ID: 3524801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activities and subcellular localization of cathepsin B and cysteine proteinase inhibitors in human ovarian carcinoma.
    Haczyńksa H; Gerber J; Osada J; Warwas M
    Acta Biochim Pol; 1997; 44(1):113-20. PubMed ID: 9241362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin B in cells of two rat sarcomas with different rates of spontaneous metastasis.
    Krepela E; Veselý P; Chaloupková A; Zicha D; Urbanec P; Rasnick D; Vicar J
    Neoplasma; 1989; 36(5):529-40. PubMed ID: 2812149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose controls cathepsin expression in Ras-transformed fibroblasts.
    Tournu C; Obled A; Roux MP; Deval C; Ferrara M; Béchet DM
    Arch Biochem Biophys; 1998 Dec; 360(1):15-24. PubMed ID: 9826424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.